# Atropine in the Treatment of Myopia Study in Malaysia

> **NCT07329777** · PHASE3 · RECRUITING · sponsor: **IDB VisionCare SDN BHD** · enrollment: 144 (estimated)

## Conditions studied

- Myopia Progression

## Interventions

- **DRUG:** Low dose atropine sulfate eye drops
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07329777
- **Lead sponsor:** IDB VisionCare SDN BHD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-17
- **Primary completion:** 2027-09
- **Final completion:** 2029-09
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2026-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07329777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07329777, "Atropine in the Treatment of Myopia Study in Malaysia". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT07329777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*